These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients. Gross HS. Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459 [No Abstract] [Full Text] [Related]
6. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial. Zwanikken GJ. Psychiatr Neurol Neurochir; 1973 Jul; 76(2):83-92. PubMed ID: 4573494 [No Abstract] [Full Text] [Related]
10. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia. Simpson GM, Varga V. Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063 [No Abstract] [Full Text] [Related]
16. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses. Svestka J, Náhunek K. Act Nerv Super (Praha); 1972 Sep; 14(2):93-4. PubMed ID: 4557145 [No Abstract] [Full Text] [Related]
18. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach. Baro F, Van Lommel R, Dom R, De Mesmaecker L. Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015 [No Abstract] [Full Text] [Related]